Alice Eberhardt

Alice Eberhardt is currently the Director Value Evidence Generation & Global HTA Operations at Otsuka Pharmaceutical Companies Europe. Prior to their current role, Alice held positions at AbbVie and Allergan as an Associate Director in HEOR, focusing on developing and executing evidence generation programs. Before that, Alice was the National Medical Science Manager at Mundipharma Germany GmbH & Co. KG, managing a team and overseeing medical education content generation. With a background in Biochemistry and Molecular Biology, Alice also has a Diploma of Education in Biology and recently completed an MBA Essentials program at The London School of Economics and Political Science.